Inotek Pharmaceuticals Corp (ITEK): Great Point Partners Adds to Its Position

Page 7 of 10 – SEC Filing

CUSIP No.  45780V102	13G	Page 7 of 9 Pages

	2. Dr. Jeffrey R. Jay, M.D.
	(a) Amount beneficially owned:  1,366,500
	(b) Percent of class:  5.07%1
	(c) Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote:  0
	(ii) Shared power to vote or to direct the vote:  1,366,500
	(iii) Sole power to dispose or to direct the disposition of:  0
	(iv) Shared power to dispose or to direct the disposition of:  1,366,500
	3. Mr. David Kroin
	(a) Amount beneficially owned:  1,366,500
	(b) Percent of class:  5.07%1
	(c) Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote:  0
	(ii) Shared power to vote or to direct the vote:  1,366,500
	(iii) Sole power to dispose or to direct the disposition of:  0
	(iv) Shared power to dispose or to direct the disposition of:  1,366,500

Item 5.                    Ownership of Five
Percent or Less of a Class

If
this statement is being filed to report the fact that as of the date hereof each of the Reporting Persons has ceased to be the
beneficial owner of more than five percent of the class of securities, check the following [ ].

Item 6.                   Ownership of More
than Five Percent on Behalf of Another Person:

See Item 4.

Item 7.                    Identification and
Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company

Not Applicable.

Item 8.                    Identification and
Classification of Members of the Group

Not Applicable.

Item 9.                    Notice of Dissolution
of Group

Not Applicable.